Bystolic and Interstitial lung disease - a phase IV clinical study of FDA data
Summary:
Interstitial lung disease is reported as a side effect among people who take Bystolic (nebivolol hydrochloride), especially for people who are female, 60+ old, also take Celebrex, and have Inflammation.
The phase IV clinical study analyzes which people have Interstitial lung disease when taking Bystolic. It is created by eHealthMe based on reports of 18,660 people who have side effects when taking Bystolic from the FDA, and is updated regularly.
What is Bystolic?
Bystolic has active ingredients of nebivolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 20,662 Bystolic users. Check the latest studies of Bystolic.
What is Interstitial lung disease?
Interstitial lung disease is found to be associated with 1,500 drugs and 1,839 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.
18,660 people reported to have side effects when taking Bystolic.
Among them, 23 people (0.12%) have Interstitial lung disease.
Among these 23 people:
What is the gender of people who have Interstitial lung disease when taking Bystolic? *
- female: 60.87 %
- male: 39.13 %
What is the age of people who have Interstitial lung disease when taking Bystolic? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 4.55 %
- 50-59: 9.09 %
- 60+: 86.36 %
What are other drugs people take besides Bystolic? *
- Synthroid: 11 people, 47.83%
- Celebrex: 11 people, 47.83%
- Vitamin D: 8 people, 34.78%
- Prilosec: 8 people, 34.78%
- Vitamin C: 7 people, 30.43%
- Fish Oil: 7 people, 30.43%
- Flonase: 7 people, 30.43%
- Faslodex: 7 people, 30.43%
- Calcium: 7 people, 30.43%
- Ibrance: 7 people, 30.43%
What are other side effects people have besides Interstitial lung disease? *
- Rash Pruritic (redness with itching): 6 people, 26.09%
- Dyspnea (difficult or laboured breathing): 6 people, 26.09%
- Blood Glucose Increased: 3 people, 13.04%
- Influenza Like Illness: 3 people, 13.04%
- Joint Pain: 2 people, 8.70%
- Disease Progression: 2 people, 8.70%
- Fall: 2 people, 8.70%
- Dyspnea Exertional: 2 people, 8.70%
- Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 2 people, 8.70%
- Renal Cell Carcinoma (a kidney cancer): 2 people, 8.70%
What are the existing conditions these people have? *
- Breast Cancer Metastatic: 6 people, 26.09%
- Itching: 6 people, 26.09%
- Chronic Thyroiditis (long lasting inflammation of thyroid gland): 6 people, 26.09%
- Hot Flush (sudden feelings of heat): 6 people, 26.09%
- Hypersensitivity: 6 people, 26.09%
- Traumatic Arthritis (inflammation of joint due to injury): 6 people, 26.09%
- Incontinence (lack of moderation or self-control): 6 people, 26.09%
- Inflammation: 6 people, 26.09%
- Vitamin D Decreased: 4 people, 17.39%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 13.04%
* Approximation only. Some reports may have incomplete information.
Do you take Bystolic and have Interstitial lung disease?
- Check whether Interstitial lung disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Bystolic:
- Bystolic (20,662 reports)
Interstitial lung disease treatments and more:
- Interstitial lung disease (69,102 reports)
How severe was Interstitial lung disease and when was it recovered:
Expand to all the drugs that have ingredients of nebivolol hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bystolic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Interstitial lung disease:
- Interstitial lung disease (1,500 drugs)
Browse all the conditions that are associated with Interstitial lung disease:
- Interstitial lung disease (1,839 conditions)
Related publications that referenced our studies
- Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
- Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
- Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
- Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on nebivolol hydrochloride (the active ingredients of Bystolic) and Bystolic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Eptifibatide and Ambien - 2 seconds ago
- Methotrexate Lpf vs. Vimovo, side effect and effectiveness comparison - 11 seconds ago
- Duragesic-100 vs. Gralise, side effect and effectiveness comparison - 18 seconds ago
- Drug interactions of Diphenhydramine Hydrochloride and Nystatin - 41 seconds ago
- Could Multihance cause Rash Erythematous? - 45 seconds ago
- Drug interactions of Adderall and Glucagon - 54 seconds ago
- Could Chantix cause Blood Iron Decreased? - a minute ago
- Drug interactions of Coumadin and Cilostazol - a minute ago
- Drug interactions of Adderall 10 and Cozaar - a minute ago
- Drug interactions of Dexmedetomidine and Erythromycin - a minute ago